Countries South Korea
MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea
MEDICOX secures distribution right for ORAMED's oral insulin in South Korea after phase 3 of FDA approval- Contract scale up to 18...
November 21, 2022 | News
Lunit to Supply AI Platform to Australia's BreastScreen NSW Machine Reading Project
Lunit's INSIGHT MMG solution has been selected for mammogram screening in Australia's BreastScreen NSW's AI evaluation and clinical integration...
November 17, 2022 | News
Standigm Synthetic Research Center successfully accelerates drug discovery in its first year
Standigm, the workflow AI-driven drug discovery company, today announced the celebration of its Synthetic Research Center's first year. In the last 12 mont...
November 17, 2022 | News
Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
HitGen will apply its DNA-encoded library (DEL) technology platform centered around the design, synthesis and screening of thousands of DELs that collectiv...
November 14, 2022 | News
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research
Lunit to present three abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping. Lunit's presentations this year will highl...
November 08, 2022 | News
Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA
The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based therapy for atopic dermatitis. 'BRE-AD01' is being develop...
November 07, 2022 | News
Samyang Holdings' Lafullen Makes Splash in Korean Medical Aesthetics Market
- Successfully demonstrated Lafullen's safety and efficacy at autumn medical symposiums - Shared treatment protocols and clinical cases to lecturers by sp...
November 01, 2022 | News
Polyplus and ENcell sign MOU for gene therapy discovery and optimization projects in Korea
“ENCell is working to accelerate viral vector CMO business via a collaboration with Polyplus.”, said Dr. Jong Wook Chang, CEO of ENCell. &ldquo...
October 28, 2022 | News
Lunit Joins World Economic Forum Global Innovators Community
Lunit invited to join the World Economic Forum's Global Innovators Community, an invitation-only group of the world's most promising start-ups and scale-...
October 27, 2022 | News
Samsung Biologics Reports Third Quarter 2022 Financial Results
Recorded consolidated revenue of KRW 873 billion in Q3'22 Recorded consolidated operating profit of KRW 324.7 billion in Q3'...
October 27, 2022 | News
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available...
October 26, 2022 | News
SK bioscience Appoints New Executives towards Global Business Growth
Global experts continue to join SK bioscience, while its U.S. corporate entity is being established Company plans to strategically invest in personnel, ...
October 24, 2022 | News
Samsung Biologics obtains three global ISO certifications
Receives accreditation for information security management system, information security in cloud services, and anti-bribery management systems F...
October 14, 2022 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
